Inhibitex's Series C Round

Inhibitex raised a round of funding on June 12, 2000.

Inhibitex is a biopharmaceutical company that is pursuing the development and commercialization of products for the infectious disease market. Inhibitex has a proprietary technology platform that util…

Articles about Inhibitex's Series C Round: